WHO ICTRP trial
Tolvaptan tablets oral administration 15mg daily for 7 days, multi…
ChiCTR2500100646 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100646 |
|---|---|
| Public title | Tolvaptan tablets oral administration 15mg daily for 7 days, multi administration pharmacokinetic study in cirrhotic patients in China |
| Scientific title | Tolvaptan tablets oral administration 15mg daily for 7 days, multi administration pharmacokinetic study in cirrhotic patients in China |
| Primary sponsor | Renji Hospital Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | liver cirrhosis |
| Interventions | Test group:Tolvaptan tablets were taken orally 15mg daily for 7 days |
| Registration date | Apr 11, 2025 |
| Target size | Test group:11 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: